Elevated TRPV6 is associated with poor prognosis in pancreatic cancer; moreover, knockdown of TRPV6 decreased Bcl-2 and increased BAX in Capan-2 cells, inhibiting proliferation and migration, while promoting apoptosis [191]. Here, TRPV6 is linked to familial pancreatic carcinoma.